Pediatric Leukemia
FDA Oncologic Drugs Advisory Committee to review clofarabine
Published in Cancer Weekly, October 19th, 2004
The company previously filed a New Drug Application with the FDA for approval of clofarabine for the treatment of refractory or relapsed acute leukemia in children. The Prescription Drug User Fee Act (PDUFA) response date for this application is December 30, 2004.
"We look forward to the ODAC hearing," said ILEX Chief Medical Officer Steve Weitman, MD.
"This review is particularly important because in addition to the regulatory achievement this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-10-19)
More Articles from Cancer Weekly
- Brain Cancer
Cannabinoids have several means for controlling glioma growth - Cancer Vaccine
Antitumor responses promoted by bone marrow from immunized donors - Head and Neck Cancer
Nitric oxide accelerates regression in head and neck cancer - Prostate Cancer
Gene expression in androgen independent disease characterized - Wilms Tumor
Shorter course of chemotherapy beneficial for children with Wilms tumor - Adenovirus Vaccine
Simian virus-tainted adenovirus vaccine does not increase cancer risk - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
